TACTILE SYSTEMS TECHNOLOGY I (TCMD) Stock Fundamental Analysis
NASDAQ:TCMD - Nasdaq - US87357P1003 - Common Stock - Currency: USD
Overall TCMD gets a fundamental rating of 6 out of 10. We evaluated TCMD against 189 industry peers in the Health Care Equipment & Supplies industry. TCMD is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. TCMD is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings would make TCMD suitable for value investing!
1. Profitability
1.1 Basic Checks
TCMD had positive earnings in the past year.
In the past year TCMD had a positive cash flow from operations.
In multiple years TCMD reported negative net income over the last 5 years.
In the past 5 years TCMD always reported a positive cash flow from operatings.
1.2 Ratios
TCMD's Return On Assets of 5.69% is amongst the best of the industry. TCMD outperforms 85.56% of its industry peers.
TCMD has a better Return On Equity (7.83%) than 82.35% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.23%, TCMD belongs to the top of the industry, outperforming 82.35% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.69% | ||
| ROE | 7.83% | ||
| ROIC | 6.23% |
ROA(3y)2.94%
ROA(5y)0.73%
ROE(3y)2.6%
ROE(5y)-0.37%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 5.79%, TCMD is in the better half of the industry, outperforming 77.54% of the companies in the same industry.
In the last couple of years the Profit Margin of TCMD has remained more or less at the same level.
TCMD's Operating Margin of 7.57% is fine compared to the rest of the industry. TCMD outperforms 74.33% of its industry peers.
TCMD's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 51.35%, TCMD perfoms like the industry average, outperforming 43.85% of the companies in the same industry.
TCMD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.57% | ||
| PM (TTM) | 5.79% | ||
| GM | 51.35% |
OM growth 3YN/A
OM growth 5Y6.44%
PM growth 3YN/A
PM growth 5Y-0.06%
GM growth 3Y3.35%
GM growth 5Y-0.43%
2. Health
2.1 Basic Checks
TCMD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for TCMD has been increased compared to 1 year ago.
Compared to 5 years ago, TCMD has more shares outstanding
Compared to 1 year ago, TCMD has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 4.52 indicates that TCMD is not in any danger for bankruptcy at the moment.
TCMD has a better Altman-Z score (4.52) than 75.40% of its industry peers.
The Debt to FCF ratio of TCMD is 0.69, which is an excellent value as it means it would take TCMD, only 0.69 years of fcf income to pay off all of its debts.
TCMD's Debt to FCF ratio of 0.69 is amongst the best of the industry. TCMD outperforms 91.44% of its industry peers.
A Debt/Equity ratio of 0.11 indicates that TCMD is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.11, TCMD perfoms like the industry average, outperforming 58.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.11 | ||
| Debt/FCF | 0.69 | ||
| Altman-Z | 4.52 |
ROIC/WACC0.71
WACC8.8%
2.3 Liquidity
TCMD has a Current Ratio of 4.36. This indicates that TCMD is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.36, TCMD is in the better half of the industry, outperforming 72.19% of the companies in the same industry.
TCMD has a Quick Ratio of 3.90. This indicates that TCMD is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 3.90, TCMD is doing good in the industry, outperforming 75.40% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.36 | ||
| Quick Ratio | 3.9 |
3. Growth
3.1 Past
TCMD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -40.83%.
TCMD shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.86% yearly.
TCMD shows a small growth in Revenue. In the last year, the Revenue has grown by 6.76%.
TCMD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.11% yearly.
EPS 1Y (TTM)-40.83%
EPS 3YN/A
EPS 5Y4.86%
EPS Q2Q%14.29%
Revenue 1Y (TTM)6.76%
Revenue growth 3Y12.08%
Revenue growth 5Y9.11%
Sales Q2Q%10.22%
3.2 Future
The Earnings Per Share is expected to grow by 23.42% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 9.23% on average over the next years. This is quite good.
EPS Next Y17.31%
EPS Next 2Y23.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.86%
Revenue Next 2Y9.23%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 20.45, TCMD is valued on the expensive side.
Based on the Price/Earnings ratio, TCMD is valued cheaper than 85.56% of the companies in the same industry.
TCMD is valuated rather cheaply when we compare the Price/Earnings ratio to 29.36, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 17.43, which indicates a rather expensive current valuation of TCMD.
Based on the Price/Forward Earnings ratio, TCMD is valued cheaper than 85.03% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of TCMD to the average of the S&P500 Index (22.65), we can say TCMD is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.45 | ||
| Fwd PE | 17.43 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TCMD indicates a rather cheap valuation: TCMD is cheaper than 95.19% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of TCMD indicates a rather cheap valuation: TCMD is cheaper than 98.40% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.14 | ||
| EV/EBITDA | 8.67 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of TCMD may justify a higher PE ratio.
TCMD's earnings are expected to grow with 23.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.18
PEG (5Y)4.21
EPS Next 2Y23.42%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for TCMD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
14.52
-0.1 (-0.68%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners95.76%
Inst Owner Change-2.47%
Ins Owners1.72%
Ins Owner Change0%
Market Cap348.48M
Analysts80
Price Target21.42 (47.52%)
Short Float %6.08%
Short Ratio5.87
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.49
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.38%
Min EPS beat(2)15.79%
Max EPS beat(2)24.97%
EPS beat(4)4
Avg EPS beat(4)30.17%
Min EPS beat(4)15.79%
Max EPS beat(4)53.45%
EPS beat(8)8
Avg EPS beat(8)444.14%
EPS beat(12)9
Avg EPS beat(12)287.89%
EPS beat(16)11
Avg EPS beat(16)199.03%
Revenue beat(2)0
Avg Revenue beat(2)-3.74%
Min Revenue beat(2)-5.72%
Max Revenue beat(2)-1.75%
Revenue beat(4)1
Avg Revenue beat(4)-1.92%
Min Revenue beat(4)-5.72%
Max Revenue beat(4)1.21%
Revenue beat(8)3
Avg Revenue beat(8)-0.26%
Revenue beat(12)7
Avg Revenue beat(12)1.22%
Revenue beat(16)10
Avg Revenue beat(16)0.58%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-268%
EPS NY rev (1m)-5.16%
EPS NY rev (3m)-5.16%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.45 | ||
| Fwd PE | 17.43 | ||
| P/S | 1.19 | ||
| P/FCF | 9.14 | ||
| P/OCF | 8.57 | ||
| P/B | 1.61 | ||
| P/tB | 2.44 | ||
| EV/EBITDA | 8.67 |
EPS(TTM)0.71
EY4.89%
EPS(NY)0.83
Fwd EY5.74%
FCF(TTM)1.59
FCFY10.95%
OCF(TTM)1.69
OCFY11.67%
SpS12.21
BVpS9.02
TBVpS5.95
PEG (NY)1.18
PEG (5Y)4.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.69% | ||
| ROE | 7.83% | ||
| ROCE | 8.62% | ||
| ROIC | 6.23% | ||
| ROICexc | 10.8% | ||
| ROICexgc | 21.51% | ||
| OM | 7.57% | ||
| PM (TTM) | 5.79% | ||
| GM | 51.35% | ||
| FCFM | 13.02% |
ROA(3y)2.94%
ROA(5y)0.73%
ROE(3y)2.6%
ROE(5y)-0.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y15.26%
ROICexc growth 3YN/A
ROICexc growth 5Y1.86%
OM growth 3YN/A
OM growth 5Y6.44%
PM growth 3YN/A
PM growth 5Y-0.06%
GM growth 3Y3.35%
GM growth 5Y-0.43%
F-Score8
Asset Turnover0.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.11 | ||
| Debt/FCF | 0.69 | ||
| Debt/EBITDA | 0.8 | ||
| Cap/Depr | 36.94% | ||
| Cap/Sales | 0.86% | ||
| Interest Coverage | 10.53 | ||
| Cash Conversion | 140.32% | ||
| Profit Quality | 224.92% | ||
| Current Ratio | 4.36 | ||
| Quick Ratio | 3.9 | ||
| Altman-Z | 4.52 |
F-Score8
WACC8.8%
ROIC/WACC0.71
Cap/Depr(3y)35.17%
Cap/Depr(5y)50.34%
Cap/Sales(3y)0.85%
Cap/Sales(5y)0.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.83%
EPS 3YN/A
EPS 5Y4.86%
EPS Q2Q%14.29%
EPS Next Y17.31%
EPS Next 2Y23.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.76%
Revenue growth 3Y12.08%
Revenue growth 5Y9.11%
Sales Q2Q%10.22%
Revenue Next Year9.86%
Revenue Next 2Y9.23%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.95%
EBIT growth 3YN/A
EBIT growth 5Y16.13%
EBIT Next Year117.31%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y14.3%
FCF growth 3Y420.83%
FCF growth 5YN/A
OCF growth 1Y13.39%
OCF growth 3Y149.11%
OCF growth 5Y74.54%